IARC monographs: 40 years of evaluating carcinogenic hazards to humans

Environmental Health Perspectives

Volumn 123, Issue 6, 2015, Pages 507-514

  Pearce, Neil ^a   Blair, Aaron ^b   Vineis, Paolo ^c   Ahrens, Wolfgang ^d   Andersen, Aage ^e   Anto, Josep M ^f   Armstrong, Bruce K ^g   Baccarelli, Andrea A ^h   Beland, Frederick A ⁱ   Berrington, Amy ^b   Bertazzi, Pier Alberto ^j   Birnbaum, Linda S ^k   Brownson, Ross C ^l   Bucher, John R ^m   Cantor, Kenneth P ⁿ   Cardis, Elisabeth ^o   Cherrie, John W ^p   Christiani, David C ^h   Cocco, Pierluigi ^q   Coggon, David ^r   Comba, Pietro ^s   Demers, Paul A ^t   Dement, John M ^u   Douwes, Jeroen ^v   Eisen, Ellen A ^w   Engel, Lawrence S ^x   Fenske, Richard A ^y   Fleming, Lora E ^z   Fletcher, Tony ^a   Fontham, Elizabeth ^aa   Forastiere, Francesco ^ab   Frentzel Beyme, Rainer ^ac   Fritschi, Lin ^ad   Gerin, Michel ^ae   Goldberg, Marcel ^af   Grandjean, Philippe ^ag   Grimsrud, Tom K ^e   Gustavsson, Per ^ah   Haines, Andy ^a   Hartge, Patricia ^b   Hansen, Johnni ^ai   Hauptmann, Michael ^aj   Heederik, Dick ^ak   Hemminki, Kari ^al   Hemon, Denis ^am   Hertz Picciotto, Irva ^an   Hoppin, Jane A ^ao   Huff, James ^m   Jarvholm, Bengt ^ap   Kang, Daehee ^aq   Karagas, Margaret R ^ar   Kjaerheim, Kristina ^e   Kjuus, Helge ^as   Kogevinas, Manolis ^o,at   Kriebel, David ^au   Kristensen, Petter ^as   Kromhout, Hans ^ak   Laden, Francine ^h   Lebailly, Pierre ^av   Lemasters, Grace ^aw   Lubin, Jay H ^b   Lynch, Charles F ^ax   Lynge, Elsebeth ^ay   Mannetje, Andreat ^v   McMichael, Anthony J ^az   McLaughlin, John R ^ba   Marrett, Loraine ^bb   Martuzzi, Marco ^bc   Merchant, James A ^ax   Merler, Enzo ^bd   Merletti, Franco ^be   Miller, Anthony ^bb   Mirer, Franklin E ^bf   Monson, Richard ^h   Nordby, Karl Cristian ^as   Olshan, Andrew F ^x   Parent, Marie Elise ^bg   Perera, Frederica P ^bh   Perry, Melissa J ^bi   Pesatori, Angela Cecilia ^j   Pirastu, Roberta ^s   Porta, Miquel ^bj   Pukkala, Eero ^bk   Rice, Carol ^aw   Richardson, David B ^x   Ritter, Leonard ^bl   Ritz, Beate ^bm   Ronckers, Cecile M ^bn   Rushton, Lesley ^bo   Rusiecki, Jennifer A ^bp   Rusyn, Ivan ^bq   Samet, Jonathan M ^br   Sandler, Dale P ^m   de Sanjose, Silvia ^bs   Schernhammer, Eva ^h   Costantini, Adele Seniori ^bt   Seixas, Noah ^y   Shy, Carl ^x   Siemiatycki, Jack ^ae   Silverman, Debra T ^b   Simonato, Lorenzo ^bu   Smith, Allan H ^w   Smith, Martyn T ^w   Spinelli, John J ^bv   Spitz, Margaret R ^bw   Stallones, Lorann ^bx   Stayner, Leslie T ^by   Steenland, Kyle ^bz   Stenzel, Mark ^ca   Stewart, Bernard W ^cb   Stewart, Patricia A ^cc   Symanski, Elaine ^cd   Terracini, Benedetto ^ce   Tolbert, Paige E ^bz   Vainio, Harri ^cf   Vena, John ^cg   Vermeulen, Roel ^ak   Victora, Cesar G ^ch   Ward, Elizabeth M ^ci   Weinberg, Clarice R ^m   Weisenburger, Dennis ^cj   Wesseling, Catharina ^ah   Weiderpass, Elisabete ^ah,ck,cl   Zahm, Shelia Hoar ^e   more..

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^e CANCER REGISTRY OF NORWAY   (Norway)

^f UNIVERSITAT POMPEU FABRA   (Spain)

^g UNIVERSITY OF SYDNEY   (Australia)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^j UNIVERSITY OF MILAN   (Italy)

^k NATIONAL INSTITUTES OF HEALTH   (United States)

^l USA   (United States)

^m NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

ⁿ KP Cantor Environmental LLC   (United States)

^o INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^p INSTITUTE OF OCCUPATIONAL MEDICINE   (United Kingdom)

^q UNIVERSITY OF CAGLIARI   (Italy)

^r UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^s SAPIENZA UNIVERSITY OF ROME   (Italy)

^t CANCER CARE ONTARIO   (Canada)

^u DUKE UNIVERSITY MEDICAL CENTER   (United States)

^v MASSEY UNIVERSITY   (New Zealand)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x IL   (United States)

^y UNIVERSITY OF WASHINGTON   (United States)

^z UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^aa Department of Oral and Craniofacial Biology   (United States)

^ab DEPARTMENT OF EPIDEMIOLOGY   (Italy)

^ac UNIVERSITY OF BREMEN   (Germany)

^ad CURTIN UNIVERSITY   (Australia)

^ae UNIVERSITÉ DE MONTRÉAL   (Canada)

^af UMS 011   (France)

^ag UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^ah KAROLINSKA INSTITUTE   (Sweden)

^ai DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^aj NETHERLANDS CANCER INSTITUTE   (Netherlands)

^ak UTRECHT UNIVERSITY   (Netherlands)

^al GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^am INSERM   (France)

^an UNIVERSITY OF CALIFORNIA   (United States)

^ao NORTH CAROLINA STATE UNIVERSITY   (United States)

^ap UMEÅ UNIVERSITY   (Sweden)

^aq Seoul National University College of Medicine   (South Korea)

^ar DARTMOUTH MEDICAL SCHOOL   (United States)

^as NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^at NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^au UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^av UNIVERSITÉ DE CAEN   (France)

^aw UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^ax UNIVERSITY OF IOWA   (United States)

^ay UNIVERSITY OF COPENHAGEN   (Denmark)

^az The Australian National University   (Australia)

^ba PUBLIC HEALTH ONTARIO   (Canada)

^bb UNIVERSITY OF TORONTO   (Canada)

^bc WORLD HEALTH ORGANIZATION   (Switzerland)

^bd Local Health Authority   (Italy)

^be UNIVERSITY OF TURIN   (Italy)

^bf CITY UNIVERSITY OF NEW YORK   (United States)

^bg UNIVERSITÉ LAVAL   (Canada)

^bh Universitat Autònoma de Barcelona ^*  (United States)

^bi GEORGE WASHINGTON UNIVERSITY   (United States)

^bj UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^bk FINNISH CANCER REGISTRY   (Finland)

^bl UNIVERSITY OF GUELPH   (Canada)

^bm UNIVERSITY OF CALIFORNIA   (United States)

^bn EMMA CHILDREN S HOSPITAL   (Netherlands)

^bo Imperial College London   (United Kingdom)

^bp Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^bq TEXAS A AND M UNIVERSITY   (United States)

^br UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^bs CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^bt CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^bu UNIVERSITY OF PADOVA   (Italy)

^bv UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^bw BAYLOR COLLEGE OF MEDICINE   (United States)

^bx Department of Environmental and Radiological Health Sciences   (United States)

^by UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^bz EMORY UNIVERSITY   (United States)

^ca Exposure Assessment Applications LLC   (United States)

^cb South Eastern Sydney Illawarra Public Health Unit   (Australia)

^cc Stewart Exposure Assessments LLC   (United States)

^cd UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^ce UNIVERSITY OF TURIN   (Italy)

^cf FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^cg MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^ch FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^ci AMERICAN CANCER SOCIETY   (United States)

^cj CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^ck UNIVERSITY OF TROMSØ   (Norway)

^cl FOLKHÄLSAN RESEARCH CENTER   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CHLORPHENOTANE; FORMALDEHYDE;

BOOK; CANCER RISK; CARCINOGENICITY; COFFEE; ELECTROMAGNETIC RADIATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HAZARD ASSESSMENT; HEALTH PROGRAM; HUMAN; INFORMATION RETRIEVAL; NONHUMAN; NOTE; PRIORITY JOURNAL; RISK FACTOR; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; NEOPLASM; ORGANIZATION AND MANAGEMENT; PUBLIC HEALTH; PUBLICATION;

BIOMEDICAL RESEARCH; CARCINOGENS, ENVIRONMENTAL; HUMANS; INTERNATIONAL AGENCIES; NEOPLASMS; PUBLIC HEALTH; PUBLICATIONS;

EID: 84930511271     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1409149     Document Type: Note

References (45)

1. Ahlbom A, Axelson O, Støttrup Hansen ES, Hogstedt C, Jensen J, Olsen J. 1990. Interpretation of “negative studies” in occupational epidemiology. Scand J Work Environ Health 16:153–157.
2. Blair A, Saracci R, Vineis P, Cocco P, Forastiere F, Grandjean P, et al. 2009. Epidemiology, public health, and the rhetoric of false positives. Environ Health Perspect 117:1809–1813; doi:10.1289/ ehp.0901194.
3. Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ. 2008. False-positive results in cancer epidemiology: A plea for epistemological modesty. J Natl Cancer Inst 100:988–995.
4. Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ. 2009. Authors’ response. A further plea for adherence to the principles under-lying science in general and the epidemiologic enterprise in particular. Int J Epidemiol 38:678–679.
5. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. 2009. Introduction to Meta-Analysis. West Sussex, England:Wiley.
6. Brownson RC, Chriqui JF, Stamatakis KA. 2009. Understanding evidence-based public health policy. Am J Public Health 99:1576–1583.
7. Checkoway H, Pearce N, Kriebel D. 2004. Research Methods in Occupational Epidemiology. 2nd ed. New York:Oxford University Press.
8. Elwood M. 2007. Critical Appraisal of Epidemiological Studies and Clinical Trials. 3rd ed. New York:Oxford University Press.
9. Epidemiology Monitor. 2012. Epidemiologists speak out about the challenge of false positives in cancer epidemiology. Epidemiology Monitor 33(11):9–10.
10. Erren TC. 2011. IARC’s plea for traditional ‘expert’ working groups—a recipe for problems? [Letter]. Int J Epidemiol 40:1727–1728.
11. Espina C, Porta M, Schüz J, Hernández Aguado I, Percival RV, Dora C, et al. 2013. Environmental and occupational interventions for primary prevention of cancer: A cross-sectorial policy framework. Environ Health Perspect 121:420–426; doi:10.1289/ehp.1205897.
12. European Food Safety Authority. 2013. Scientific Opinion on the Hazard Assessment of Endocrine Disruptors: Scientific Criteria for Identification of Endocrine Disruptors and Appropriateness of Existing Test Methods for Assessing Effects Mediated by These Substances on Human Health and the Environment. Available: http://www.efsa.europa.eu/en/search/ doc/3132.pdf [accessed 21 April 2015].
13. Gallo V, Egger M, McCormack V, Farmer PB, Ioannidis JPA, Kirsch-Volders M, et al. 2011. STrengthening the Reporting of OBservational studies in Epidemiology–Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med 8:e1001117; doi:10.1371/journal.pmed.1001117.
14. Grandjean P. 2005. Non-precautionary aspects of toxicology. Toxicol Appl Pharmacol 207(2 suppl):652–657.
15. Haseman JK. 2000. Using the NTP database to assess the value of rodent carcinogenicity studies for determining human cancer risk. Drug Metab Rev 32:169–186.
16. Hill AB. 1965. The environment and disease: associa-tion or causation? Proc R Soc Med 58:295–300.
17. IARC (International Agency for Research on Cancer). 1972. Some inorganic substances, chlorinated hydrocarbons, aromatic amines, N-nitroso compounds, and natural products. IARC Monogr Eval Carcinog Risk Hum 1:17–184. Available: http://monographs.iarc.fr/ENG/Monographs/vol1-42/mono1.pdf [accessed 20 April 2015].
18. IARC (International Agency for Research on Cancer). 2006. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Preamble. Available: http://monographs.iarc.fr/ENG/ Preamble/CurrentPreamble.pdf [accessed 20 April 2015].
19. IARC (International Agency for Research on Cancer). 2014a.Preamble. IARC Monogr Eval Carcinog Risk Hum 106:7–30. Available: http://monographs.iarc.fr/ENG/Monographs/vol106/mono106.pdf [accessed 20 April 2015].
20. IARC (International Agency for Research on Cancer). 2014b. Report of the Advisory Group to Recommend Priorities for IARC Monographs during 2010–2014. Available: http://monographs.
21. IARC.fr/ENG/Publications/internrep/14-001.pdf [accessed 20 April 2015].
22. IARC (International Agency for Research on Cancer). 2014c. Trichloroethylene, tetrachloro ethylene, and some other chlorinated agents.
23. IARC Monogr Eval Carcinog Risk Hum 106:35–512. Available: http://monographs.iarc.fr/ENG/Monographs/vol106/ mono106.pdf [accessed 20 April 2015].
24. Ioannidis JPA. 2005. Why most published research findings are false. Plos Med 2:e124; doi:10.137/journal.pmed.0020124.
25. Kabat GC. 2008. Hyping Health Risks: Environmental Hazards in Daily Life and the Science Of Epidemiology. New York:Columbia Univeristy Press.
26. Kabat G. 2012. How Activism Distorts the Assessment of Health Risks. Forbes, 20 November. Available: http://www.forbes.com/sites/realspin/2012/11/20/how-activism-distorts-the-assessment-of-healthrisks/ [accessed 20 April 2015].
27. MacMahon B, Yen S, Trichopoulos D, Warren K, Nardi G. 1981. Coffee and cancer of the pancreas. N Engl J Med 304:630–633.
28. Maronpot RR, Flake G, Huff J. 2004. Relevance of animal carcinogenesis findings to human cancer predictions and prevention. Toxicol Pathol 32(suppl 1):40–48.
29. McLaughlin JK, Boffetta P, La Vecchia C, Lipworth L, Blot WJ, Tarone RE. 2011. Authors’ response. Problems with IARC’s ‘expert’ working groups [Letter]. Int J Epidemiol 40:1728–1729.
30. McLaughlin JK, Lipworth L, Tarone RE, La Vecchia C, Blot WJ, Boffetta P. 2010. Authors’ response. Re: A further plea for adherence to the principles underlying science in general and the epidemiologic enterprise in particular [Letter]. Int J Epidemiol 39:1679–1680.
31. McLaughlin JK, Tarone RE. 2013. False positives in cancer epidemiology. Cancer Epidemiol Biomarkers Prev 22:11–15.
32. Michaels D. 2006. Manufactured uncertainty: Protecting public health in the age of contested science and product defense. Ann NY Acad Sci 1076:149–162.
33. Michaels D. 2008. Doubt is Their Product: How Industry’s Assault on Science Threatens Your Health. New York:Oxford University Press.
34. National Research Council. 2009. Science and Decisions: Advancing Risk Assessment. Washington, DC:National Academies Press. Available: http://www.nap.edu/openbook.php?record_id=12209 [accessed 20 April 2015].
35. Rothman KJ, Greenland S, Lash TL. 2008. Modern Epidemiology. 3rd ed. Philadelphia:Lippincott Williams & Wilkins.
36. Samet JM. 2000. Epidemiology and policy: The pump handle meets the new millennium. Epidemiol Rev 22:145–154.
37. Siemiatycki J, Wacholder S, Dewar R, Cardis E, Greenwood C, Richardson L. 1988. Degree of confounding bias related to smoking, ethnic group, and socioeconomic status in estimates of the associations between occupation and cancer. J Occup Med 30:617–625.
38. Straif K, Loomis D, Guyton K, Grosse Y, Lauby- Secretan B, El Ghissassi F, et al. 2014. Future priorities for the IARC monographs. Lancet Oncol 15:683–684.
39. Swedish Criteria Group for Occupational Standards. 2013. Scientific Basis for Swedish Occupational Standards XXXII. Available: https://gupea.ub.gu.se/bitstream/2077/34986/1/gupea_2077_34986_1.pdf [accessed 21 April 2015].
40. Taubes G. 1995. Epidemiology faces its limits. Science 269:164–169.
41. Tomatis L. 1976. The IARC Program on the Evaluation of Carcinogenic Risk of Chemicals to Man. Ann NY Acad Sci 271:396–409.
42. Tomatis L. 2002. The IARC Monographs Program: Changing attitudes towards public health. Int J Occup Environ Health 8:144–152.
43. Ward EM, Schulte PA, Straif K, Hopf NB, Caldwell JC, Carreón T, et al. 2010. Research recommendations for selected IARC-classified agents. Environ Health Perspect 118:1355–1362; doi:10.1289/ehp.0901828.
44. Wild CP, Cogliano VJ. 2011. A plea on behalf of expert evaluation and the experts involved [Letter]. Int J Epidemiol 40:253.
45. Wild CP, Straif K. 2011. Authors’ response. Expert working groups—a reliable recipe [Letter]. Int J Epidemiol 40:1730–1731.